IL33 and neoplasm: It seems that host cells producing IL-33, such as cancer-associated fibroblasts (CAFs), are responsible for tumor progression by inducing migration, epithelial–mesenchymal transition (EMT), invasion and proliferation of cancer cells, while in cancer cells, IL-33 is responsible for the improvement of anti-tumor immune response [33,34].